You are viewing: France Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The France Long Read Sequencing Market was valued at $19.2 Million in 2024 and projected to reach to $80.7 Million by 2029, representing a compound annual growth rate of 33.3%. France's long read sequencing market is poised for exceptional growth, expanding from $19.2 million in 2024 to $80.7 million by 2029.

France Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Long Read Sequencing Market Trends and Insights

  • This represents a compound annual growth rate of 33.3%, reflecting France's increasing adoption of advanced genomic technologies across research institutions, clinical diagnostics, and pharmaceutical development.
  • France is positioning itself as a key hub for precision medicine in Europe, with significant investments in genomic infrastructure and bioinformatics capabilities driving market acceleration. The French market benefits from strong government support for genomic research initiatives and a well-established healthcare system that increasingly integrates long read sequencing into clinical workflows.
  • France's pharmaceutical and biotechnology sectors are leveraging long read sequencing for drug discovery and development, while academic institutions are expanding their genomic research capabilities.
  • Between 2024 and 2029, France is expected to see heightened demand from both public and private sector organizations seeking to unlock insights from complex genomic data..

Key Market Statistics

  • CAGR (2024-2029) 33.3% CAGR
  • Market Size, 2024 ~USD 19.2 Million
  • Forecast, 2029 ~USD 80.7 Million
  • Country France

France Long Read Sequencing Market Overview

Rapid Market Expansion :

France's long read sequencing market is growing at 33.3% CAGR, significantly outpacing global growth of 32.8%, demonstrating strong regional momentum and investment in genomic infrastructure.

Strong Clinical Adoption :

French hospitals and diagnostic centers are increasingly integrating long read sequencing into clinical workflows, driven by improved accuracy in detecting structural variants and complex genomic rearrangements.

Research & Pharma Investment :

French pharmaceutical companies and research institutions are leveraging long read sequencing for drug discovery and development, positioning France as a hub for advanced genomic research in Europe.

Government Support & Funding :

French government initiatives and EU research programs are providing substantial funding for genomic technologies, accelerating adoption across academic centers and private laboratories.

France Long Read Sequencing Market Dynamics

  • This trajectory reflects increasing integration of long read technologies in clinical diagnostics, personalized medicine, and cancer genomics across French healthcare institutions.
  • The market benefits from strong government support, robust pharmaceutical R&D spending, and growing collaboration between academic research centers and commercial providers. Key drivers include rising demand for accurate structural variant detection, expanding applications in rare disease diagnosis, and France's commitment to genomic medicine initiatives.
  • As reimbursement frameworks evolve and sequencing costs decline, adoption will accelerate across both public and private healthcare sectors, establishing France as a leading European market for advanced sequencing technologies..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • France's long read sequencing market is valued at $19.2 million in 2024 and is forecast to grow to $80.7 million by 2029, representing a 33.3% CAGR.
    • France is leveraging long read sequencing across clinical diagnostics, pharmaceutical R&D, and academic research to advance precision medicine initiatives.
    • Government support and investment in genomic infrastructure are accelerating adoption of long read sequencing technologies throughout France.
    • France's pharmaceutical and biotech sectors are increasingly integrating long read sequencing into drug discovery workflows to enhance competitive advantage.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    France Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    FRANCE: LONG-READ SEQUENCING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTE9.512.716.220.927.536.548.967.933.2
    HOSPITALS, CLINICS, AND DIAGNOSTIC LABS2.945.16.78.911.916.122.634.6
    OTHER END USER2.12.73.34.25.36.78.611.427.8
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES4.25.67.19.212.11621.429.633
    TOTAL18.72531.84153.771.194.9131.632.9

    Target Audience

    • Sequencing Technology Providers : Equipment manufacturers and platform developers need France-specific market data to calibrate sales strategies, identify key customer segments, and optimize product positioning for French healthcare institutions.
    • Diagnostic Laboratory Operators : Clinical and research laboratories in France require market insights to assess growth potential, benchmark against competitors, and make informed investment decisions in long read sequencing capabilities.
    • Pharmaceutical & Biotech Companies : French and international pharma firms need detailed market analysis to evaluate genomics R&D opportunities, identify collaboration partners, and understand the competitive landscape in France.
    • Healthcare Investors & Consultants : Investment firms and management consultants require France-specific market data to evaluate investment opportunities, assess portfolio companies, and develop market entry strategies.
    • Hospital & Healthcare System Administrators : French hospital networks and healthcare systems need market intelligence to justify capital investments in sequencing infrastructure, understand adoption trends, and plan genomic medicine initiatives.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation for France ($19.2M in 2024) with verified 33.3% CAGR projections through 2029, enabling accurate business planning and investment decisions specific to the French market.
    • Competitive Landscape Intelligence : Understand France-specific competitive dynamics, key players, market share distribution, and strategic positioning to identify partnership opportunities and market entry strategies.
    • Clinical & Regulatory Insights : Access detailed analysis of French healthcare adoption patterns, reimbursement frameworks, regulatory requirements, and clinical integration pathways for long read sequencing technologies.
    • Pharmaceutical & Research Sector Analysis : Gain insights into French pharma R&D spending on genomics, academic research initiatives, and collaboration opportunities within France's robust life sciences ecosystem.
    • Strategic Growth Opportunities : Identify high-potential segments, emerging applications in rare disease diagnosis, and expansion opportunities within French hospitals, diagnostic labs, and research institutions.

    Frequently asked questions

    What is the current size of France's long read sequencing market?

    France's long read sequencing market was valued at $19.2 million in 2024 and is expected to reach $80.7 million by 2029.

    What is the projected growth rate for long read sequencing in France?

    France's long read sequencing market is projected to grow at a compound annual growth rate (CAGR) of 33.3% from 2024 to 2029.

    Which sectors are driving long read sequencing adoption in France?

    France's pharmaceutical, biotechnology, clinical diagnostics, and academic research sectors are primary drivers of long read sequencing adoption.

    How is France supporting long read sequencing market growth?

    France is supporting market growth through government-backed genomic research initiatives, healthcare system integration, and investments in bioinformatics infrastructure.

    What applications of long read sequencing are most prevalent in France?

    In France, long read sequencing is primarily used for drug discovery, clinical diagnostics, complex genomic analysis, and precision medicine research.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status